Plasmapheresis effectively abrogates severe liver toxicity of pegaspargase in a patient with acute lymphoblastic leukemia

Ann Hematol. 2024 Aug;103(8):3269-3271. doi: 10.1007/s00277-024-05789-7. Epub 2024 May 11.
No abstract available

Publication types

  • Letter
  • Case Reports

MeSH terms

  • Adult
  • Asparaginase* / adverse effects
  • Asparaginase* / therapeutic use
  • Chemical and Drug Induced Liver Injury / etiology
  • Female
  • Humans
  • Male
  • Plasmapheresis*
  • Polyethylene Glycols* / therapeutic use
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / therapy

Substances

  • Asparaginase
  • pegaspargase
  • Polyethylene Glycols